Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin-Reference-Cited by-同舟云学术

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

Published:2020-09-25 Issue:9 Volume:15 Page:e0237802
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Woodhouse Ryan^ORCID,Li Meijuan,Hughes Jason,Delfosse David,Skoletsky Joel,Ma Pei,Meng Wei,Dewal Ninad,Milbury Coren,Clark Travis,Donahue Amy,Stover Dan,Kennedy Mark,Dacpano-Komansky Jennifer,Burns Christine,Vietz Christine,Alexander Brian,Hegde Priti,Dennis Lucas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer;TB Ribeiro;Int J Technol Assess Health Care,2019

2. Oncologist use and perception of large panel next-generation tumor sequencing;AM Schram;Ann Oncol,2017

3. An overview of precision oncology basket and umbrella trials for clinicians;JJH Park;CA Cancer J Clin,2020

4. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study;JK Sicklick;Nat Med,2019

5. Utility of genomic assessment of blood-derived circulating tumor DNA (ctDNA) in patients with advanced lung adenocarcinoma;MC Schwaederlé;Clin Cancer Res,2017

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic instabilities in hepatocellular carcinoma: biomarkers and application in immunotherapies;Annals of Hepatology;2024-11

2. Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab;npj Precision Oncology;2024-09-14

3. Prospects and Current Challenges of Extracellular Vesicle-Based Biomarkers in Cancer;Biology;2024-09-04

4. Homologous Recombination Repair Testing Patterns and Outcomes in mCRPC by Alteration Status and Race;ClinicoEconomics and Outcomes Research;2024-09

5. Analytic validation of anFGFR-focused cell-free DNA liquid biopsy assay (FGFR-Dx);2024-09-01